Significant PFS Improvement with Ibrutinib-Rituximab Compared to Immunochemotherapy in Previously Untreated Patients with Mantle Cell Lymphoma By Ogkologos - October 24, 2025 192 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ENRICH study Source RELATED ARTICLESMORE FROM AUTHOR Pembrolizumab Plus Weekly Paclitaxel, With Or Without Bevacizumab, Improves OS in Patients With Platinum-Resistant Recurrent Ovarian Cancer EMA Recommends Extension of Indications for Serplulimab Adding Relacorilant to Nab-paclitaxel Prolongs OS in Patients with Platinum-Resistant Ovarian Cancer MOST POPULAR Woman Battles Breast Cancer While Pregnant, Delivers Healthy Baby Boy October 27, 2020 No Glucose? Pancreatic Cancer May Have a Ready Energy Alternative June 22, 2023 Crazy Bride Called Off Her Wedding Because Her Guests Refused To... April 22, 2019 Bus Driver Wears Different Costume Each Day To Make Kids Smile... January 27, 2022 Load more HOT NEWS Development of Secondary T-Cell Cancers After the Use of CAR T-Cells... How to Find the Right Hospice Care Program for You or... New Radiation Therapy Won’t Leave Breast Cancer Patients with Unwanted Tattoo... Female Representation at the Top of the Oncology Field Has Hit...
